SONOMA PHARMACEUTICALS INC

SNOA · NASDAQ

Updated at 2026-10-14 09:31:18

$1.18-4.06%
Today's High
$1.25
Today’s Low
$1.17
SONOMA PHARMACEUTICALS INC (SNOA) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$1.24
Previous Close
$1.23
Volume
14.88K
Market Cap
$5.88M
P/E Ratio
--
EPS
$-1.22

Previous Day Range

$1.22$1.29

52-Week Range

$0.85$4.44

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Headquarters
5445 CONESTOGA COURT, BOULDER, CO, UNITED STATES, 80301
Country
US
Listing Date
2007-01-26
Fiscal Year End
March
Shares Outstanding
4.79M
CIK
0001367083

Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company is headquartered in Woodstock, Georgia.

Financial Metrics

Revenue

2026-06-30

$6.4M

2026-03-31

$5.56M

2025-12-31

$4.34M

2025-09-30

$5.6M

Operating Expenses

2026-06-30

$2.61M

2026-03-31

$2.53M

2025-12-31

$2.32M

2025-09-30

$2.45M

Net Income

2026-06-30

-$330K

2026-03-31

-$581K

2025-12-31

-$819K

2025-09-30

-$534K

Net Profit Margin

2026-06-30

-5.15%

2026-03-31

-10.44%

2025-12-31

-18.83%

2025-09-30

-9.52%

Earnings Per Share

2026-06-30

$0.02

2026-03-31

$-0.15

2025-12-31

$-0.48

2025-09-30

$-0.32

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$298K

2026-03-31

-$318K

2025-12-31

-$644K

2025-09-30

-$301K

Effective Tax Rate

2026-06-30

--

2026-03-31

-16.9%

2025-12-31

13.69%

2025-09-30

26.94%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.